Whois & Analysis for gilead.com

Gilead Sciences is an American biopharmaceutical company that discovers, develops and commercializes therapeutics.

For many years since the company was founded, the company concentrated primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza.

In 2006, Gilead acquired two companies which were developing drugs to treat patients with pulmonary diseases.

The company currently produces a range of commercially available products, most notably the Hepatitis C drugs: Harvoni and Sovaldi.

A biopharmaceutical, also known as a biologic(al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.

Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy.

Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues.

They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation.

Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Biomedical research (or experimental medicine) is in general simply known as medical research.

It is the basic research (also called bench science or bench research), applied research, or translational research conducted to aid and support the development of knowledge in the field of medicine.

Innovation can be defined simply as a "new idea, device or method".

However, innovation is often also viewed as the application of better solutions that meet new requirements, unarticulated needs, or existing market needs.

This is accomplished through more-effective products, processes, services, technologies, or business models that are readily available to markets, governments and society.

The term "innovation" can be defined as something original and more effective and, as a consequence, new, that "breaks into" the market or society.

It is related to, but not the same as, invention.

Innovation is often manifested via the engineering process.

The opposite of innovation is exnovation.